Hantech Bio-Technology Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	778.54	748.42	625.14	302.52	240.29
Revenue Growth (YoY)	4.02%	19.72%	106.65%	25.90%	-9.90%
Cost of Revenue	489.65	442.68	344.29	175.89	139.27
Gross Profit	288.9	305.74	280.85	126.63	101.03
Selling, General & Admin	103.16	98.17	88.34	61.11	55.51
Research & Development	12.18	10.13	7.37	8.09	6.9
Operating Expenses	115.91	108.28	95.15	69.8	61.36
Operating Income	172.98	197.47	185.71	56.84	39.67
Interest Expense	-2.98	-5.38	-2.12	-1.47	-1.55
Interest & Investment Income	3.28	1.39	0.65	0.27	0.05
Currency Exchange Gain (Loss)	-	0.55	-0.03	2.57	-0.2
Other Non Operating Income (Expenses)	-0.27	0.96	0.46	0.07	0.45
EBT Excluding Unusual Items	173.01	194.99	184.68	58.28	38.42
Gain (Loss) on Sale of Assets	-	-0.35	-0.11	-0.55	-0
Pretax Income	173.01	194.64	184.57	57.73	38.42
Income Tax Expense	33.93	39.22	37.04	11.87	7.33
Earnings From Continuing Operations	139.08	155.42	147.53	45.86	31.09
Minority Interest in Earnings	-0.03	0.26	0.59	1.61	1.47
Net Income	139.05	155.67	148.12	47.47	32.56
Net Income to Common	139.05	155.67	148.12	47.47	32.56
Net Income Growth	-10.68%	5.10%	212.00%	45.81%	-41.62%
Shares Outstanding (Basic)	30	28	28	26	23
Shares Outstanding (Diluted)	31	29	28	26	24
Shares Change (YoY)	4.66%	3.38%	8.45%	7.98%	2.60%
EPS (Basic)	4.60	5.47	5.36	1.86	1.41
EPS (Diluted)	4.54	5.32	5.23	1.82	1.35
EPS Growth	-14.71%	1.74%	188.00%	34.69%	-43.04%
Free Cash Flow	145.19	126.13	-102.03	-19.7	-34.87
Free Cash Flow Per Share	4.74	4.31	-3.60	-0.76	-1.44
Dividend Per Share	-	2.907	0.699	0.608	-
Dividend Growth	-	315.99%	14.99%	-	-
Gross Margin	37.11%	40.85%	44.93%	41.86%	42.04%
Operating Margin	22.22%	26.38%	29.71%	18.79%	16.51%
Profit Margin	17.86%	20.80%	23.69%	15.69%	13.55%
Free Cash Flow Margin	18.65%	16.85%	-16.32%	-6.51%	-14.51%
EBITDA	211.15	221.24	198.27	68.54	50.96
EBITDA Margin	27.12%	29.56%	31.72%	22.66%	21.21%
D&A For EBITDA	38.17	23.77	12.56	11.71	11.29
EBIT	172.98	197.47	185.71	56.84	39.67
EBIT Margin	22.22%	26.38%	29.71%	18.79%	16.51%
Effective Tax Rate	19.61%	20.15%	20.07%	20.56%	19.09%
Revenue as Reported	778.54	-	-	-	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.